James Tam, private equity partner at Bain Capital, discusses the outlook for China's private equity market in the wake of U.S. tariffs.
.
Health
U.S. tariffs: There is 'clear potential for supply chain realignment,' says Bain Capital

James Tam, private equity partner at Bain Capital, discusses the outlook for China's private equity market in the wake of U.S. tariffs.